# Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)

> **NCT03104478** · — · COMPLETED · sponsor: **The Lymphoma Academic Research Organisation** · enrollment: 219 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **PROCEDURE:** Biological samples collection

## Key facts

- **NCT ID:** NCT03104478
- **Lead sponsor:** The Lymphoma Academic Research Organisation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-09
- **Primary completion:** 2019-10-11
- **Final completion:** 2021-09-04
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2021-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03104478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03104478, "Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03104478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*